All Programs

Dr. John L. Barr Memorial Fund

Overview John L. Barr, M.D. was an internist at Kaiser Permanente for 25 years, where he started a clinic for patients with chronic pain. I...

Dr. Edward T. Rancic Memorial Fund for Cancer Research

Overview The Dr. Edward T. Rancic Memorial Fund provides support for a post-doctoral fellowship focused on renal cell cancer—the most com...

Dr. Anita Roberts Memorial Fund

Overview The Dr. Anita Roberts Memorial Fund awards travel scholarships for graduate students and post-doctoral fellows to present their wo...

Dean R. O’Neill Renal Cell Cancer Research Fund

Overview Our Fund, the Dean R. O’Neill Renal Cell Cancer Research Fund, helps recruit the next generation of physician-scientists and cli...

Biomarkers Consortium – Measurable residual disease in acute myeloid leukemia (MRD in AML)

Acute myeloid leukemia (AML) is a heterogeneous genetic disease. According to the National Cancer Institute (NCI), an estimated 20,240 new A...

Biomarkers Consortium – CSC Scientific Symposium

The Problem cancer research is a large and diverse field, making it difficult to coordinate efforts across its many subfields, which are fo...

Biomarkers Consortium – ctDNA Quality Control Materials Project

The Problem Tumor DNA circulating in bodily fluids offers researchers a valuable tool to study, and thus to treat, cancer. Yet the wide var...

Biomarkers Consortium – Neurofilament as a Blood-Based Biomarker of Neurodegeneration in Familial Frontotemporal Degeneration (FTD)

The Problem The earliest stages of FTD are hard to detect until the disease has progressed and damage is more permanent. Experts believe th...

Biomarkers Consortium – Treatments Against RA and Effect on FDG PET-CT (TARGET Biomarker Study)

The Problem Rheumatoid arthritis (RA) is currently difficult to treat and people with RA are at increased risk for developing cardiovascula...

Biomarkers Consortium – Vol-PACT Phase II: Advanced metrics and modeling with Volumetric CT for Precision Analysis of Clinical Trial results

The Problem The cancer research field lacks well-tested biomarkers to measure disease progression and to predict how patients respond to tr...

Cancer Research Fund

The Cancer Research Fund enables individuals to support cancer research at the National Cancer Institute (NCI). Goals Enable individua...

CarMollNat Muscular Dystrophy Fund

"In memorium for my parents, Molly Harris and Nathan Harris, and my brother, Merton Harris- They were so much to so many.” - Carol-Ann Ha...

Clinical Center Drug Donations

Overview The Clinical Center In-Kind Drug Donation Program provides pharmaceuticals that are donated through the public-private partnership...

Combining Epitope-Based Vaccine Design with Informatics-Based Evaluation to Obtain a Universal Influenza Vaccine

The Problem Every year, an estimated 291,000 to 646,000 people worldwide die from seasonal influenza-related respiratory illnesses. Current...

Comprehensive Cellular Vaccine Immune Monitoring Consortium

The Problem The development of a safe and broadly effective vaccine against HIV/AIDS has been elusive and, despite decades of effort, eve...

Biomarkers Consortium – The Performance of Novel Cardiac Biomarkers in the General U.S. Population

The Problem Cardiovascular disease is one of the most lethal conditions in the United States, yet Researchers lack the tools needed to asse...

Remote Digital Monitoring and Patient-Centric Medical Product Development

Overview The use of remote digital monitoring technologies (smartphone apps, wearables, ingestibles, implantable, and mobile device-based t...

Biomarkers Consortium – PROGRESS OA: Clinical Evaluation and Qualification of Osteoarthritis Biomarkers

Overview The Biomarkers Consortium’s PROGRESS OA - Clinical Evaluation and Qualification of Osteoarthritis Biomarkers Project is the seco...

Biomarkers Consortium – Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in Alzheimer’s Disease

The Problem Early treatment of Alzheimer’s disease requires early diagnosis. Yet available methods to diagnose early AD are expensive or ...

Biomarkers Consortium – NiP-Metastatic Prostate Cancer

Overview Metastatic castration-resistant prostate cancer (mCRPC) is the second leading cause of cancer death of American men. Over 80% of t...

Biomarkers Consortium – Mucosal Healing in UC: Definition, Treatment Target and Clinical Endpoints

The Problem Mucosal healing is an important outcome in clinical trials of drugs to treat ulcerative colitis, yet Researchers lack a standar...

Biomarkers Consortium – Inflammatory Markers for Early Detection and Subtyping of Neurodegenerative and Mood Disorders

The Problem Neurodegenerative and psychiatric conditions such as Alzheimer’s disease and Major Depressive Disorder present very different...

Biomarkers Consortium – I-SPY TRIAL-2 (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and MoLecular Analysis): An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy

Overview The I-SPY 2 trial was setup to accelerate the pace of qualifying effective novel agents for breast cancer by testing new agents in...

Biomarkers Consortium – Bone Quality Project

The Problem Patients with osteoporosis, other bone diseases or increased risk for bone fractures have diminished bone strength and quality,...

African Centers of Excellence in Bioinformatics

The African Centers of Excellence in Bioinformatics is a strategic public-private partnership of the National Institute of Allergy and Infec...